Using a special eye test called OCT can help understand cognitive challenges in MS, but MRI may still be more useful overall.
The study looked at 137 people with relapsing-remitting MS, focusing on how well they could think and remember. They used two tests: one to check eye health (OCT) and another called MRI to see brain health. They found that when certain eye layers were thicker, people did better on a thinking test. However, when they also looked at MRI results, the connection wasn’t as strong, suggesting that MRI might be better for predicting thinking skills. This means OCT is helpful but might not give extra information beyond what MRI already tells us.
MS patients and caregivers should pay attention because understanding how to measure thinking skills is important for managing MS. If you notice memory or thinking issues, knowing which tests are most helpful can guide you to the right care. Healthcare providers can use this information to choose the best ways to assess and help patients. Just like checking a car's engine and tires, using the best tools helps keep your health in check. Overall, these findings might help patients get the right support and resources sooner.
This study looked at a specific group of MS patients, so the results might not apply to everyone. Some may still experience cognitive changes that aren't detected by these tests. It's important for patients and caregivers to keep discussing any cognitive concerns with their healthcare team, even if the tests seem normal.
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More5/1/2026
Study finds CD29 marks blood B cells that can enter the brain and become antibody-producing cells in
Read More5/1/2026
Study finds early detection, lower spinal fluid virus, and PML‑IRIS relate to better 1‑year outcomes
Read More5/1/2026
Study found fewer hospital diagnoses of antibody-positive autoimmune encephalitis during COVID-19, b
Read More3/1/2026
Study shows C5 inhibitors given during or soon after NMOSD attacks helped most patients stabilize or
Read More3/1/2026
Early OCT eye scans can often distinguish MOGAD from NMOSD optic neuritis, helping guide faster trea
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Multiple sclerosis (Houndmills, Basingstoke, England) often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.